To use all functions of this page, please activate cookies in your browser.
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Enerkem and Sinobioway Group create a joint venture to build over 100 biofuel facilities in China
Enerkem Inc. announced it has signed an agreement with Sinobioway Group worth over C$125M in the form of equity investment in Enerkem Inc., future licenses, equipment manufacturing and sales, as well as for the creation of a major joint venture that will lead the construction of over 100 Enerkem state-of-the-art facilities in China by 2035. The announcement was made in the presence of the Premier of Quebec, Philippe Couillard, during his China trade mission.
Sinobioway, a flagship conglomerate in China's bio-industry, will help accelerate Enerkem's global growth by opening the Chinese market to Enerkem's pioneering waste-to-biofuels technology. This joint venture will spearhead the development of a clean economy, reducing air pollution by producing renewable fuels from non-recyclable garbage.
"Our breakthrough clean technology produces a much needed low-carbon transportation fuel and sustainable waste management solution to help China achieve its climate change objectives," said Vincent Chornet, President and CEO of Enerkem. "We are proud to collaborate with a leading Chinese bio-industrial partner to expand our commercial footprint."
"We are excited to partner with a leading Canadian cleantech company to help meet our country's commitment to reducing greenhouse gas emissions and move towards renewable energy," said Dr. Aihua Pan, Sinobioway's Chairman.
- joint ventures
- Merck Receives Patent for CRISPR Technology in China
- Sensitive new assay detects hepatitis B infection in single liver cells and serum
- Diamond ring architecture of a protein complex
- Merck Invests Additional €40 Million to Enhance Manufacturing and Distribution in Asia
- Multifunctional platform for the delivery of gene therapeutics